http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2478827-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36310ab39fe797510fbf5c0408149b4f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 2009-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecd3b2d3bba88f1a1dd4e6bdb48afe6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed0883c99414948f58ea3ee19b6c23af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27b963454b4c319426f2f57237ff53a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a48126798911423d95900d4b5578c0e3
publicationDate 2014-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2478827-T3
titleOfInvention Use of histone deacetylase inhibitors for the treatment of Philadelphia negative myeloproliferative syndromes
abstract Diethyl- [6- (4-hydroxycarbamoyl-phenylcarbamoyloxymethyl) -naphthalen-2-yl methyl] -ammonium chloride, or other pharmaceutically acceptable salts and / or solvates, for use in the treatment of negative Philadelphia myeloproliferative syndromes, characterized in that The daily dose is from 10 to 150 mg per patient.
priorityDate 2008-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426150744
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3458
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID405790
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3065
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404125
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID478040
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404126
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID738624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487788
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID487309
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15181
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID433759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452090224
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192302
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID393965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414857470
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100689317
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109644000
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20652
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID490325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4842
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID457553
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4328717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497421
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25712
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID574282
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15978
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID432017
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID44446
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81782
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373339
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395506
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396054
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403801
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID464259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4261
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID549637
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281237
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421003434
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38565
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID504287
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID297893
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6942
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID84578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9804992
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9865515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87259244
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396991

Total number of triples: 85.